← Open Payments lookup

JOHN GRANDGENETT: Open Payments

NPI 1174537849 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$857 in 41 payments from 11 companies in 2025. Trend: 2023 $709 · 2024 $1,073 · 2025 $857

Food & beverage: $857
CompanyPaymentsAmount
Astellas Pharma US Inc7$233
Novo Nordisk Inc9$160
ABBVIE INC.11$157
Otsuka America Pharmaceutical, Inc.3$65
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$59
Medtronic, Inc.1$54
PFIZER INC.3$44
Novartis Pharmaceuticals Corporation1$35
Biogen, Inc.1$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$16

Products named: Veozah, Wegovy, REXULTI, CAPLYTA, QULIPTA, SYMPLICITY G3, Ozempic, VRAYLAR.

Industry payments across NE — which companies pay providers there.